Literature DB >> 25458540

Computational studies to predict or explain G protein coupled receptor polypharmacology.

Kenneth A Jacobson1, Stefano Costanzi2, Silvia Paoletta3.   

Abstract

Since G protein-coupled receptors (GPCRs) belong to a very large superfamily of evolutionarily related receptors (>800 members in humans), and due to the rapid progress on their structural biology, they are ideal candidates for polypharmacology studies. Broad screening and bioinformatics/chemoinformatics have been applied to understanding off-target effects of GPCR ligands. It is now feasible to approach the question of GPCR polypharmacology using molecular modeling and the available X-ray GPCR structures. As an example, large and sterically constrained adenosine derivatives (potent adenosine receptor ligands with low conformational freedom and multiple extended substituents) were screened for binding at diverse receptors. Unanticipated off-target interactions, including at biogenic amine receptors, were then modeled using a structure-based approach to provide a consistent understanding of recognition. A conserved Asp in TM3 changed its role from counterion for biogenic amines to characteristic H-bonding to adenosine. The same systematic approach could potentially be applied to many GPCRs or other receptors using other sets of congeneric ligands. Published by Elsevier Ltd.

Entities:  

Keywords:  G protein-coupled receptors; bioinformatics; chemoinformatics; molecular modeling

Mesh:

Substances:

Year:  2014        PMID: 25458540      PMCID: PMC4314400          DOI: 10.1016/j.tips.2014.10.009

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  54 in total

1.  Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4.

Authors:  Michael M Mysinger; Dahlia R Weiss; Joshua J Ziarek; Stéphanie Gravel; Allison K Doak; Joel Karpiak; Nikolaus Heveker; Brian K Shoichet; Brian F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

Review 2.  Polypharmacology - foe or friend?

Authors:  Jens-Uwe Peters
Journal:  J Med Chem       Date:  2013-08-22       Impact factor: 7.446

Review 3.  The GPCR crystallography boom: providing an invaluable source of structural information and expanding the scope of homology modeling.

Authors:  Stefano Costanzi; Keyun Wang
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 4.  Classification of scaffold-hopping approaches.

Authors:  Hongmao Sun; Gregory Tawa; Anders Wallqvist
Journal:  Drug Discov Today       Date:  2011-10-26       Impact factor: 7.851

Review 5.  Structure-based drug screening for G-protein-coupled receptors.

Authors:  Brian K Shoichet; Brian K Kobilka
Journal:  Trends Pharmacol Sci       Date:  2012-04-13       Impact factor: 14.819

Review 6.  Rhodopsin and the others: a historical perspective on structural studies of G protein-coupled receptors.

Authors:  Stefano Costanzi; Jeffrey Siegel; Irina G Tikhonova; Kenneth A Jacobson
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  GPCR agonist binding revealed by modeling and crystallography.

Authors:  Vsevolod Katritch; Ruben Abagyan
Journal:  Trends Pharmacol Sci       Date:  2011-09-06       Impact factor: 14.819

8.  Homology modeling of class a G protein-coupled receptors.

Authors:  Stefano Costanzi
Journal:  Methods Mol Biol       Date:  2012

9.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

10.  The origin of GPCRs: identification of mammalian like Rhodopsin, Adhesion, Glutamate and Frizzled GPCRs in fungi.

Authors:  Arunkumar Krishnan; Markus Sällman Almén; Robert Fredriksson; Helgi B Schiöth
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

View more
  15 in total

1.  Structural signatures of DRD4 mutants revealed using molecular dynamics simulations: Implications for drug targeting.

Authors:  Nidhi Jatana; Lipi Thukral; N Latha
Journal:  J Mol Model       Date:  2015-12-17       Impact factor: 1.810

2.  In silico prediction of chemical mechanism of action via an improved network-based inference method.

Authors:  Zengrui Wu; Weiqiang Lu; Dang Wu; Anqi Luo; Hanping Bian; Jie Li; Weihua Li; Guixia Liu; Jin Huang; Feixiong Cheng; Yun Tang
Journal:  Br J Pharmacol       Date:  2016-11-01       Impact factor: 8.739

3.  Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.

Authors:  Antonella Ciancetta; Kenneth A Jacobson
Journal:  Methods Mol Biol       Date:  2018

Review 4.  Polypharmacology of conformationally locked methanocarba nucleosides.

Authors:  Kenneth A Jacobson; Dilip K Tosh; Kiran S Toti; Antonella Ciancetta
Journal:  Drug Discov Today       Date:  2017-08-03       Impact factor: 7.851

Review 5.  Structural insights into emergent signaling modes of G protein-coupled receptors.

Authors:  Ieva Sutkeviciute; Jean-Pierre Vilardaga
Journal:  J Biol Chem       Date:  2020-06-22       Impact factor: 5.157

6.  Structure-Based Scaffold Repurposing for G Protein-Coupled Receptors: Transformation of Adenosine Derivatives into 5HT2B/5HT2C Serotonin Receptor Antagonists.

Authors:  Dilip K Tosh; Antonella Ciancetta; Eugene Warnick; Steven Crane; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2016-12-09       Impact factor: 7.446

7.  5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.

Authors:  Yao Peng; John D McCorvy; Kasper Harpsøe; Katherine Lansu; Shuguang Yuan; Petr Popov; Lu Qu; Mengchen Pu; Tao Che; Louise F Nikolajsen; Xi-Ping Huang; Yiran Wu; Ling Shen; Walden E Bjørn-Yoshimoto; Kang Ding; Daniel Wacker; Gye Won Han; Jianjun Cheng; Vsevolod Katritch; Anders A Jensen; Michael A Hanson; Suwen Zhao; David E Gloriam; Bryan L Roth; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2018-02-01       Impact factor: 41.582

8.  A Key Opinion Leader interview: insight into the research and career of Dr KA Jacobson.

Authors:  Kenneth A Jacobson; Claudia Palmer
Journal:  Expert Opin Ther Pat       Date:  2014-12-12       Impact factor: 6.674

Review 9.  New paradigms in GPCR drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

10.  Computational polypharmacology comes of age.

Authors:  Giulio Rastelli; Luca Pinzi
Journal:  Front Pharmacol       Date:  2015-07-28       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.